Arcus Biosciences
RCUS· Manufacturing· Fiscal year ends in December
Terry Rosen, Ph.D. is the CEO of Arcus Biosciences and was paid $9.7M in FY2025 (Dec), up 33%.
Executives5
See all- 1Terry Rosen, Ph.D.Chief Executive Officer and DirectorFY2025
- 2Richard Markus, M.D., Ph.D.Chief Medical OfficerFY2025
- 3Juan Carlos Jaen, Ph.D.PresidentFY2025
- 4Jennifer JarrettChief Operating OfficerFY2025
- 5Robert C. Goeltz, IIChief Financial OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allArcus Biosciences paid its 5 named executives $23.9M in total in FY2025 (Dec). CEO Terry Rosen, Ph.D. was paid $9.7M of that.
| Name | |||
|---|---|---|---|
| Terry Rosen, Ph.D.Chief Executive Officer and Director | |||
| Richard Markus, M.D., Ph.D.Chief Medical Officer | Not disclosed | Not disclosed | |
| Juan Carlos Jaen, Ph.D.President | Not disclosed | ||
| Jennifer JarrettChief Operating Officer | Not disclosed | ||
| Robert C. Goeltz, IIChief Financial Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers17
See allThe FY2025 (Dec) proxy of Arcus Biosciences names 17 peer companies for pay. Among Arcus Biosciences and these peers, CEO pay was 3rd highest of 7 and total shareholder return was 2nd highest of 7.
3rd highest of 7in Arcus Biosciences and its pay peers, FY2025 (Dec) by CEO pay:
2nd highest of 7in Arcus Biosciences and its pay peers, FY2025 (Dec) by total shareholder return:
'%20fill='%23224a7c'/%3e%3c/clipPath%3e%3cclipPath%20id='clip-path-2'%3e%3cpath%20id='Path_4394'%20d='M4.892,12.4c.758.192,1.629.412,2.67.6a27,27,0,0,0,5.02.426,18.387,18.387,0,0,0,4.07-.6,15.613,15.613,0,0,1,3.2-.6,2.179,2.179,0,0,1,1.861.814,3.668,3.668,0,0,1,.542,1.724c.058.524.058.872.35,1.086a3.609,3.609,0,0,0,1.821.31c.95.02,2.268-.02,3.12-.058s1.24-.077,1.531.1a1.153,1.153,0,0,1,.485.989,10.163,10.163,0,0,0-.136,1.3,2.4,2.4,0,0,0,.717,1.142,4.087,4.087,0,0,1,.872,1.222.844.844,0,0,1-.446,1.066,5.765,5.765,0,0,1-2.171.5,10.913,10.913,0,0,0-2.326.271c-.465.194-.426.581-.155.988s.776.833,1.028,1.3a1.084,1.084,0,0,1-.136,1.357,4.056,4.056,0,0,1-1.977.814c-.814.155-1.667.194-2.442.329a12.864,12.864,0,0,0-1.978.543c-.5.175-.814.291-.969.621a.85.85,0,0,0,.427,1.163,13.866,13.866,0,0,0,2.616.5c.872.175,1.453.484,1.55,1.047a13.544,13.544,0,0,1-.368,2.229,3.628,3.628,0,0,0,.523,2.267,1.967,1.967,0,0,0,1.589.755,8,8,0,0,0,2.364-.077,8.558,8.558,0,0,0,1.822-.736,1.836,1.836,0,0,1,1.861-.1,4.294,4.294,0,0,1,1.182,2.326c.194.872.155,1.569.891,2.015a14.815,14.815,0,0,0,3.664.93A14,14,0,0,1,41.4,42.242a9.687,9.687,0,0,1,1.736,1.229A24.91,24.91,0,1,0,4.892,12.4'%20transform='translate(-4.892%20-0.176)'%20fill='%23224a7c'/%3e%3c/clipPath%3e%3c/defs%3e%3cg%20id='Group_3541'%20transform='translate(-0.094%20-0.128)'%3e%3cg%20id='Group_3282'%20transform='translate(0.094%2015.73)'%3e%3cg%20id='Group_3281'%20clip-path='url(%23clip-path)'%3e%3crect%20id='Rectangle_2848'%20width='33.837'%20height='20.982'%20transform='translate(-0.094%2033.75)%20rotate(-89.841)'%20fill='%23224a7c'/%3e%3c/g%3e%3c/g%3e%3cg%20id='Group_3284'%20transform='translate(3.563%200.128)'%3e%3cg%20id='Group_3283'%20clip-path='url(%23clip-path-2)'%3e%3crect%20id='Rectangle_2849'%20width='43.423'%20height='46.468'%20transform='translate(-0.12%2043.294)%20rotate(-89.841)'%20fill='%23224a7c'/%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board5
See all- Yasunori Kaneko, M.D.Lead independent director · 10 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive
- David Lacey, M.D.Director · 5 yr on the boardIndependentCompensation, Nominating and Corporate Governance (Chair), Science—Paid as an executive
- Linda Higgins, Ph.D.Director · 4 yr on the boardNot independentScience—Paid as an executive
- Nicole LambertDirector · 4 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- Johanna MercierDirector · 1 yr on the boardNot independent—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 21, 2026 | FY2025 |
| Annual report | 10-K | Feb 25, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 22, 2025 | FY2024 |
| Annual report | 10-K | Feb 25, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 23, 2024 | FY2023 |
| Annual report | 10-K | Feb 21, 2024 | FY2023 |
